WARRANTS (Details - IPO warrant Activity) - Warrant [Member] - IPO Warrant [Member] - $ / shares |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||
| Number of warrants outstanding, Beginning balance | 1,983,870 | 1,999,146 | |
| Average exercise price outstanding, Beginning balance | $ 1.93 | $ 1.93 | |
| Weighted average remaining contractual term, Outstanding | 1 year 7 months 13 days | 2 years 7 months 13 days | 3 years 7 months 13 days |
| Number of warrants, Exercised | (3,039) | (15,276) | |
| Average exercise price, Exercised | $ 1.93 | $ 1.93 | |
| Number of warrants outstanding, Ending balance | 1,980,831 | 1,983,870 | 1,999,146 |
| Average exercise price outstanding, Ending balance | $ 1.93 | $ 1.93 | $ 1.93 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|